The Rundown

Market update for Wednesday December 24, 2025Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In today’s episode:The S&P 500 hits another record as GDP growth comes in hotter than expectedApple CEO Tim Cook buys $3M worth of Nike stock as the company struggles to turn things aroundGoogle-backed AI fleet management company Motive files for an IPODynavax surges after agreeing to a $2.2B acquisition by SanofiIntel slides after reports Nvidia won’t use its chip manufacturing processTech IPOs in 2025 have disappointed investors

Market update for Tuesday December 23, 2025Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In this episode:Gold and silver prices hit new recordsNovo’s weight-loss pill gets FDA approvalGoogle buys a renewable energy firm for $4.75BTrump’s new battleship deal goes to Huntington IngallsU.S. drone stocks soar after U.S. bans foreign playersJohnson & Johnson ordered to pay $1.5B by jury in baby powder case

Market update for Monday December 22, 2025Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In this episode:Investors eye ‘Santa Claus’ rally to end the trading year Oracle founder Larry Ellison guarantees Paramount’s offer for WBDNvidia plans to ship H200 chips to China in FebruaryRocket Lab secures its largest contract everHoneywell loses $470M from FlexJet lawsuitThe new Avatar movie “Fire and Ash” disappoints in opening weekend

Kyla Scanlon and Justin Wolfers, Professor of Public Policy and Economics at University of Michigan, join the show to break down the Federal Reserve’s latest rate cut—and why growing internal dissent at the Fed actually matters. We unpack what the dot plot reveals, how markets may be misreading Jerome Powell, and whether inflation data is being misunderstood rather than manipulated. The conversation also dives into tariffs, affordability, and why cost-driven inflation hits households differently than demand-driven price spikes.

Medline just pulled off the biggest IPO of 2025, beating out higher-profile names like Circle, Klarna, and Figma despite being a company most people have never heard of. In this episode, we break down how this family-owned medical-supply giant built a massive moat, why its CEO calls it the “Costco of Healthcare,” and the risks investors should be watching.